reported that inhibition of IL-25 led to a decrease in the incidence rate of type 2 diabetes  T cells and macrophages in the primary tumor microenvironment, as well as enhanced breast tumor invasion and subsequent lung metastasis (31). The gene discussed is IL25; the disease is type 2 diabetes mellitus.